SUN Pharmaceutical Industries Limited Escitalopram Export Data — India (DGFT 2022–2026)

Name: SUN Pharmaceutical Industries Limited Escitalopram Export Records India — #6 Exporter, 293 Shipments, $10.7M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Escitalopram

India Pharmaceutical Trade Intelligence

$196.7M231 Suppliers95 CountriesHS 30049099

ExportsIndia → MOROCCO40.9%India → UNITED STATES23.6%

ImportsCANADA → India$5.3M UNITED STATES → India$18.4K

#1 Supplier: MEDISPRAY LABORATORIES #1 Buyer: CIPLA MAROC

SUN Pharmaceutical Industries Limited — Escitalopram Exporter #6 | $10.7M Trade Value | TransData Nexus | TransData Nexus

SUN Pharmaceutical Industries Limited — Escitalopram Exporter Profile

Indian Pharmaceutical Exporter · #6 for Escitalopram · $10.7M export value · DGFT Verified

SUN Pharmaceutical Industries Limited is the #6 Indian exporter of Escitalopram with $10.7M in export value and 293 verified shipments. SUN Pharmaceutical Industries Limited holds a 5.5% market share in Escitalopram exports across 11 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.

SUN Pharmaceutical Industries Limited — Escitalopram Export Profile: Buyers & Destinations

SUN Pharmaceutical Industries Limited Escitalopram export treemap — buyers and destination countries | TransData Nexus

Where Does SUN Pharmaceutical Industries Limited Export Escitalopram?

Country	Value	Shipments	Share
BELGIUM	$1.9M	102	24.1%
BRAZIL	$1.4M	56	18.1%
SRI LANKA	$1.1M	37	14.6%
MOROCCO	$1.1M	27	14.1%

Who Are the Top Buyers of Escitalopram from SUN Pharmaceutical Industries Limited?

Buyer	Country	Value	Orders
YUSEN LOGISTICS BENELUX BELGIUM	BELGIUM	$1.7M	93
M/S. RANBAXY FARMACEUTICA LTDA :	BRAZIL	$994.0K	28
MYIT MAHAR TRADING CO., LTD.	MYANMAR	$635.5K	25
RANBAXY (THAILAND) CO. LTD,	THAILAND	$553.0K	15
M/S. SUN PHARMACEUTICALS MOROCCO LL	MOROCCO	$452.5K	12
M S SUN PHARMACEUTICALS MOROCCO LL	MOROCCO	$300.0K	6
TO THE ORDER	SRI LANKA	$217.8K	6
M/S. SUN PHARMA CANADA INC	CANADA	$163.3K	5
SUN PHARMACEUTICALS MOROCCO LLC	MOROCCO	$159.1K	4
M/S. RANBAXYFARMACEUTICA LTDA	BRAZIL	$150.0K	3

SUN Pharmaceutical Industries Limited supplies Escitalopram to 44 buyers globally. The largest buyer is YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), followed by M/S. RANBAXY FARMACEUTICA LTDA : (BRAZIL) and MYIT MAHAR TRADING CO., LTD. (MYANMAR). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Escitalopram Formulations Does SUN Pharmaceutical Industries Limited Export?

Product Description / Formulation	Value	Shipments
NEXITO 5 TABLETS (Escitalopram Oxalate T	$258.8K	8
ESCITALOPRAM OXALATE TABLETS 10MG PACK:	$247.1K	5
ESCITALOPRAM OXAL TAB 10MG PACK:BOX3X10s	$214.7K	6
CILENTRA TABS 10MG(ESCITALOPRAM OXALATE	$200.0K	4
ESCITALOPRAM OXALATE TABLETS 10MG ( SERODEPS TAB 10MG ) EACH FILM-COATED TABLETCONTAINS: ESCITALOPRAM OXALATE EQ. TO ES	$199.2K	6
NEXITO 10 MG TABLETS(ESCITALOPRAM OXALAT	$198.4K	7
ESCITALOPRAM OXALATE TABLETS 10MG ( ESCI	$156.8K	13
CILENTRA TABS 10MG (ESCITALOPRAM OXALATE	$154.3K	4
ESCITALOPRAM OXALATE TABLETS 10MG ( SERO	$150.0K	3
ESIDEP TAB 10MG PACK:4X7S BATCH:PTF1038A, PTF1039A, PTF1040A EACH FILM COATED TAB CONTS. ESCITALOPRAM OXALATE EQ TO ESCI	$150.0K	3

SUN Pharmaceutical Industries Limited exports 176 distinct Escitalopram formulations including tablets, capsules, syrups, and combination drugs. The top formulation is NEXITO 5 TABLETS (Escitalopram Oxalate T with 8 shipments worth $258.8K.

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Escitalopram Exporters?

Exporters ranked immediately above and below #6 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
3	TORRENT PHARMACEUTICALS LTD	$12.1M	242	14	$50.0K
5	AUROBINDO PHARMA LIMITED	$10.9M	218	11	$50.0K
6	SUN PHARMACEUTICAL INDUSTRIES LIMITED ★	$10.7M	293	11	$36.6K
7	CIPLA LIMITED	$7.9M	218	7	$36.1K
8	GRAVITI PHARMACEUTICALS PRIVATE LIMITED	$5.4M	258	1	$20.9K

SUN Pharmaceutical Industries Limited ranks #6 among 231 Indian Escitalopram exporters. Average shipment value of $36.6K compared to the market average of $474.7K. The closest competitors by value are TORRENT PHARMACEUTICALS LTD and AUROBINDO PHARMA LIMITED.

Which Indian Ports Ship Escitalopram Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	652	11.9%
SAHAR AIR	555	10.2%
NHAVA SHEVA SEA (INNSA1)	471	8.6%
HYDERABAD ICD	369	6.8%
DELHI AIR CARGO ACC (INDEL4)	303	5.6%
DELHI AIR	287	5.3%
HYDERABAD ICD (INSNF6)	243	4.5%
HYDERABAD AIR	217	4.0%

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Escitalopram Exports

Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)

In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)

The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)

Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Escitalopram shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 302 individual customs records matching SUN Pharmaceutical Industries Limited exporting Escitalopram, covering 176 formulations to 11 countries via 44 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 95+ countries, 628+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Escitalopram

Escitalopram

SUN Pharmaceutical Industries Limited — Escitalopram Exporter Profile

SUN Pharmaceutical Industries Limited — Escitalopram Export Profile: Buyers & Destinations

Where Does SUN Pharmaceutical Industries Limited Export Escitalopram?

Who Are the Top Buyers of Escitalopram from SUN Pharmaceutical Industries Limited?

What Is India's Total Escitalopram Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?

What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Escitalopram Exports?

How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Escitalopram Exporters?

What Escitalopram Formulations Does SUN Pharmaceutical Industries Limited Export?

Regulatory Requirements: Exporting Escitalopram to Key Markets

Brazil — ANVISA

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Escitalopram Exporters?

Which Indian Ports Ship Escitalopram Exports?

What Other CNS & Psychiatric Products Does SUN Pharmaceutical Industries Limited Export?

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Escitalopram Exports

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

About SUN Pharmaceutical Industries Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Escitalopram Export Data from SUN Pharmaceutical Industries Limited

Escitalopram Stats

Company Overview

Top Products by SUN Pharmaceutical Industries Limited

Related Analysis

Need Detailed Export Data?

Data Source